Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI coach helps diabetes patients eat and move better – but only for a week

NCT ID NCT07160972

Disease control Sponsor: Li Huating Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an AI system called X Life that gives personalized diet and exercise tips to people with prediabetes or type 2 diabetes. Twenty participants used the system for 7 days via AR glasses or a smartphone. The goal was to see if people found it easy and helpful, not to measure long-term health changes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-based lifestyle guidance system (X Life) delivered via AR glasses or mobile device
What this could lead to
If successful, this could point toward a practical AI tool to help people with diabetes manage their diet and activity day-to-day.
What could go wrong
This was a very small, 7-day study with only 20 people. It focused on user experience, not long-term health outcomes, so benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Sep 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-70 years. * Prediabetes or Type 2 diabetes mellitus (diagnosed according to recognized clinical criteria). * Owns and is proficient in using a smartphone with compatible applications. * Willing and able to wear study devices (CGM, activity tracker). * Willing to use the X Life model terminal and comply with study procedures. * Able to understand and provide written informed consent (including participation in interviews). Exclusion Criteria: * Severe chronic diabetic complications or recent acute diabetic complications. * Early-onset adult T2DM. * Recent severe hypoglycemic events. * Cognitive impairment. * Pregnancy, severe hepatic/renal/thyroid disease, acute infection, psychiatric disorders affecting participation. * Planned major surgery or treatment likely to significantly impact glucose or weight during the study period. * Allergy to device materials (CGM sensor, activity tracker, AI terminal). * Any condition deemed unsuitable by the investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes

Contacts and locations

Locations

  • Shanghai Sixth People's Hospital

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.